How to Value a Manufacturing Business: 2026 Methodology, Multiples & Capital-Intensity Math

Valuing a manufacturing business is not a single-multiple exercise. It is a layered analysis of sub-vertical (machine shop versus contract manufacturer versus precision aerospace versus medical device), capital intensity (maintenance capex as a percentage of revenue, equipment age, depreciation profile), working capital efficiency (inventory turns, DSO, DPO), customer concentration, recurring contracted revenue mix, and the certifications that gate buyer interest (ISO 9001, AS9100 for aerospace, ISO 13485 and FDA registration for medical, NADCAP for nondestructive testing, ITAR for defense). Skip any one of these and the valuation you produce is materially wrong.

This guide walks an owner through the actual valuation methodology used by lower middle-market manufacturing buyers in 2026. We’ll cover the EBITDA multiple framework by size band, when to switch from EBITDA to SDE for owner-operated job shops, the four adjusters that compress or expand multiples (size premium, recurring revenue percentage, customer concentration discount, growth premium), capital-intensity math that separates reported EBITDA from underwriteable EBITDA, and the sub-vertical-specific multiple ranges buyers like Industrial Growth Partners, Audax Industrial, Trive Capital, GenNx360 Capital Partners, Cortec Group, Wynnchurch Capital, Mason Wells, and Sterling Group actually use.

The framework draws on direct work with 76+ active U.S. lower middle-market buyers — including 38 firms (50% of the network) with explicit manufacturing mandates. These buyers include manufacturing-focused PE platforms (Audax Industrial, Industrial Growth Partners, GenNx360, Trive Capital, Mason Wells, Wynnchurch Capital, Argosy Capital, Sterling Group, Cortec Group, GTCR’s industrials practice, Genstar Capital’s industrial investments, Carlyle’s industrials team), public consolidators (NYSE: APi Group [APG], NYSE: Watsco [WSO], NYSE: Comfort Systems USA [FIX], NYSE: Roper Technologies [ROP], NASDAQ: HEICO [HEI], NYSE: Atkore [ATKR]), family offices with industrial mandates, and strategic acquirers. We’re a buy-side partner. The buyers pay us when a deal closes — not you. The goal here isn’t to pitch a sale; it’s to give an honest read on what your manufacturing business is actually worth.

One realistic note before you start. If your manufacturing business does $1.8M EBITDA on $14M revenue with 6% maintenance capex and a 32% customer concentration in a single Tier-1 OEM, and you’ve seen a competitor sell for “8x EBITDA,” the math you’re running is almost certainly off. That competitor either had different earnings (TTM versus LTM versus normalized), a different concentration profile, an undisclosed earnout that re-priced the deal, or specialty certifications (AS9100 for aerospace work, ISO 13485 for medical) you don’t have. Before you anchor on a multiple, read the capital intensity and customer concentration sections below carefully.

“The mistake most manufacturing owners make is reading a Pitchbook headline that says ‘industrials traded at 8.4x in Q1’ and applying that to their $2.3M EBITDA machine shop with a 38% Boeing concentration. The headline is real. The application isn’t. Real valuation is sub-vertical math: capital intensity, customer mix, recurring revenue percentage, and the certifications that determine which buyer pool you’re actually in — not which one the trade press wrote about.”

Key Takeaways

• TEV/EBITDA multiple framework by size: sub-$10M EBITDA = 4-7x, $10-50M EBITDA = 6-9x, $50M+ EBITDA = 7-12x (per GF Data, BVR DealStats, and Pitchbook industrials data, 2024-2026 vintage).
• SDE replaces EBITDA below ~$1.5M of normalized earnings for owner-operated job shops, machine shops, and small contract manufacturers. Typical sub-$1M SDE machine shops trade 3-5x SDE.
• Capital intensity matters more than headline multiples: 4-7% maintenance capex as a percentage of revenue is typical and reduces underwriteable cash flow materially versus reported EBITDA.
• Customer concentration above 25% triggers 1-2 turn multiple discounts from disciplined LMM buyers (Audax Industrial, Industrial Growth Partners, Sterling Group, Wynnchurch); above 40% pushes deals into earnout territory.
• Inventory turns of 4-8x annually and DSO of 35-55 days are typical benchmarks. Working capital normalization at close (receivables minus payables minus held inventory) often shifts $300K-$2M+ of headline value.
• Sub-vertical multiples diverge significantly: machine shops 3-5x SDE, contract manufacturers 5-7x EBITDA, precision machining 6-8x EBITDA, aerospace (AS9100/NADCAP) 7-10x EBITDA, medical device (ISO 13485/FDA) 8-12x EBITDA.

The manufacturing valuation framework: EBITDA multiples, SDE multiples, and TEV math

Manufacturing businesses are valued primarily on TEV/EBITDA — total enterprise value divided by trailing twelve months (TTM) EBITDA — with adjustments for size, capital intensity, customer concentration, and sub-vertical. Total enterprise value (TEV) is the price a buyer pays for the operating business: equity value plus assumed debt, minus excess cash, with a working capital adjustment at close. TEV is what the buyer underwrites. The headline price you see in trade press is usually TEV, not equity value. For a manufacturing business with $4M of EBITDA and $1.5M of debt, a 6.5x TEV/EBITDA deal produces $26M of TEV, $24.5M of equity proceeds before working capital adjustment, and a wire that lands $20-22M after taxes and transaction costs.

Below roughly $1.5M of normalized earnings, valuation typically shifts from EBITDA multiples to SDE multiples. SDE (Seller’s Discretionary Earnings) is EBITDA plus the full owner compensation package: salary, bonus, benefits, owner’s health insurance, owner’s vehicle and phone, family members on payroll without market-rate roles, country club and personal travel, and similar discretionary expenses. For an owner-operated machine shop that reports $700K of EBITDA after the owner pays themselves a $180K salary plus $40K of benefits and $30K of personal expenses, true SDE is closer to $950K. The buyer at this size is an SBA-financed individual or search funder who will step into the owner role — they care about SDE, not EBITDA, because that is the cash they can extract.

The choice of metric materially changes the apparent multiple. A $700K EBITDA / $950K SDE machine shop priced at 4x SDE produces $3.8M TEV. The same business priced at 4x EBITDA produces $2.8M TEV — a $1M difference, or roughly 25-30% of the deal value. Reporting in the wrong metric for your size band is one of the most expensive mistakes manufacturing owners make. Above $1.5M-$2M of EBITDA with a real second-tier operator (plant manager, controller, sales lead) in place, you should be reporting EBITDA. Below that, with the owner still functioning as the operating brain, SDE is the honest metric.

Manufacturing TEV/EBITDA multiples in 2026 (GF Data, BVR DealStats, Pitchbook industrials): $2-5M EBITDA: 4-6x TEV/EBITDA, dominated by search funders, independent sponsors, and strategic add-ons. $5-10M EBITDA: 5-7x, the entry point for disciplined LMM PE platforms. $10-25M EBITDA: 6-8.5x, the heart of the LMM market with active competition from Audax, Industrial Growth Partners, GenNx360, Trive, Mason Wells, Wynnchurch. $25-50M EBITDA: 7-9.5x, where the upper LMM and lower middle-market PE meet (GTCR Industrials, Genstar Capital, Cortec Group, Sterling Group). $50M+ EBITDA: 8-12x, true middle-market territory, including strategic acquirers paying synergy premiums.

Sub-vertical multiples: why machine shops, contract manufacturers, aerospace and medical device trade so differently

Manufacturing is not a single market. A 4,000-square-foot machine shop running three Haas VF-2s for general industrial customers trades at a fundamentally different multiple than a NADCAP-certified precision machining operation supplying Boeing, Lockheed, and Spirit AeroSystems. The differences are not vibes — they are driven by recurring revenue percentage, customer concentration profile, certification gating, capex intensity, and the depth of the buyer pool that can write a check at all.

Machine shops (general industrial, no specialty certifications): 3-5x SDE for sub-$1M SDE; 4-6x EBITDA for $1-3M EBITDA. These are typically owner-operated job shops with 5-25 employees, $2-12M of revenue, 8-15% EBITDA margins, broad customer mix without specialty certification gating. Buyers are SBA-financed individuals, search funders, independent sponsors, and small strategic consolidators. Customer concentration risk is high (single customer often 25-40%), capital intensity is moderate (4-6% maintenance capex), and the operator is usually still doing customer-facing work. Multiple compression below 3x SDE happens when the owner is the lead programmer or estimator and the business cannot survive a 30-day owner absence.

Contract manufacturers (CMs): 5-7x EBITDA for $2-10M EBITDA, 6-8x for $10M+ EBITDA. Contract manufacturers run defined production processes for established OEM customers under multi-year supply agreements. Recurring contracted revenue (often 60-80% of revenue) supports higher multiples. Sub-verticals include plastic injection molding, metal fabrication, electronic contract manufacturing (ECM), and turn-key assembly. Examples of active LMM buyers in this space: Trive Capital (multiple plastics platforms), Mason Wells (industrial CM), Wynnchurch Capital (metal fabrication), Argosy Capital (specialty CM), and strategics like Atkore (NYSE: ATKR) acquiring electrical product CMs. Capital intensity in injection molding can run 6-9% (capex-heavy molds and presses) which compresses multiples relative to lighter-asset CMs.

Precision machining (tight-tolerance, ISO 9001 minimum): 6-8x EBITDA for $3-15M EBITDA. Precision machining serves industries where dimensional tolerances of 0.001” or better are required: medical instruments (non-implantable), industrial pumps, hydraulics, fluid power, and automotive Tier-2 supply. ISO 9001 is table stakes; ISO 13485 (medical device quality) or AS9100 (aerospace quality) opens premium buyer pools. Active buyers include GenNx360 Capital Partners, Sterling Group, Industrial Growth Partners, and strategic consolidators in fluid power (NYSE: Roper Technologies [ROP] subsidiaries, Helios Technologies, Parker Hannifin’s acquisition arm).

Aerospace (AS9100 / NADCAP): 7-10x EBITDA for $3-25M EBITDA, 8-12x for $25M+ EBITDA. Aerospace contract manufacturers and machine shops with AS9100 certification (the aerospace quality management standard) and NADCAP accreditation (special process certifications including nondestructive testing, heat treatment, chemical processing) trade at premium multiples driven by certification scarcity, OEM qualification cycles of 18-36 months that lock incumbents in, and 60%+ recurring contracted revenue from Tier-1 OEMs (Boeing, Airbus, Lockheed, Northrop, Raytheon, Spirit AeroSystems). Active aerospace LMM buyers: GenNx360, Audax Industrial, GTCR Industrials, Arlington Capital Partners, Greenbriar Equity Group, Cortec Group, plus strategic consolidators like NASDAQ: HEICO (HEI) for specialty aerospace components, TransDigm for proprietary aero parts, and Roper Technologies (NYSE: ROP) subsidiaries. ITAR-restricted work (defense) further constrains the buyer pool to U.S. control, often lifting multiples by 0.5-1 turn for the right business.

Medical device contract manufacturers (ISO 13485 / FDA registered): 8-12x EBITDA for $3-30M EBITDA. Medical device CMs operating under FDA 21 CFR Part 820 quality systems with ISO 13485 certification trade at the top of the manufacturing valuation range. The thesis is durable: 2-5 year regulatory submission and qualification cycles create deep customer lock-in, recurring contracted revenue typically exceeds 70%, end-market growth is structurally tied to demographic aging, and the buyer pool includes both PE platforms specifically focused on medical (Linden Capital Partners, Riverside’s healthcare group, GTCR Healthcare, Bain Capital Healthcare) and strategic acquirers consolidating the medical CM market. Capex intensity is higher (6-10%) but the multiple expansion more than compensates.

Capital intensity: why reported EBITDA overstates underwriteable cash flow in manufacturing

Manufacturing businesses are capital-intensive in ways that service businesses are not. A CNC machine shop, a plastic injection molder, a metal stamping operation, or an aerospace precision shop runs on equipment that depreciates in 5-15 years and requires ongoing replacement to maintain capacity. Reported EBITDA — which adds back depreciation — ignores that replacement obligation. Sophisticated buyers underwrite to EBITDA − maintenance capex, not headline EBITDA. The gap between the two is often 15-30% of reported EBITDA.

Maintenance capex benchmarks by sub-vertical (2024-2026 industry data): General machine shops: 3-5% of revenue. Precision machining: 5-7% of revenue. Plastic injection molding: 6-9% of revenue (heavy press and tooling investment). Metal stamping and forming: 5-8% of revenue. Aerospace machining (AS9100): 5-8% of revenue, plus 2-4% of revenue in tooling-specific spend. Medical device CMs: 6-10% of revenue, with cleanroom infrastructure a meaningful component. Electronic contract manufacturing: 3-5% of revenue (lighter capex, but inventory-heavy).

How buyers actually run the math. Take TTM EBITDA. Subtract a 3-year average of maintenance capex (excluding growth capex for new product lines or capacity expansion). The resulting figure — sometimes called ‘underwriteable EBITDA’ or ‘cash EBITDA’ — is what disciplined buyers actually price. A $14M revenue, $2M reported EBITDA precision machine shop with $900K of 3-year average maintenance capex (6.4% of revenue) underwrites at $1.1M of cash EBITDA — not $2M. Apply a 6x multiple to $1.1M and you get $6.6M of TEV, not $12M.

What this means for the seller. If your equipment is old and you’ve under-invested in maintenance capex for the last 3-5 years to inflate EBITDA, sophisticated buyers will catch it during quality of earnings (QoE) review and re-price the deal. Conversely, if you’ve invested aggressively in new equipment and your TTM capex is artificially elevated, a good QoE provider (Plante Moran, BDO, RSM Manufacturing & Distribution practice, Crowe, Wipfli, Eide Bailly) will normalize the run-rate to historical maintenance levels and protect the multiple. Either way, the conversation happens. Pretending capex doesn’t exist is not a strategy.

Equipment age and replacement-cycle disclosure. Buyers will request a fixed-asset register with model number, year of acquisition, accumulated depreciation, and remaining useful life for the top 20-50 pieces of equipment. They will reconcile this against your maintenance capex history. They will also ask whether any equipment is leased (operating lease versus capital lease changes the EBITDA add-back analysis materially). Owners who walk into a sale process without a clean fixed-asset register and equipment-replacement plan signal poor financial hygiene. Owners who walk in with a 10-year capex forecast tied to specific equipment age and replacement schedule signal sophistication and protect their multiple.

Working capital math: inventory turns, DSO, DPO, and the close adjustment

Working capital is the most-fought-over line item in manufacturing M&A and the one most owners are least prepared for. The buyer expects to receive normal operating working capital at close: enough inventory to run the business, enough accounts receivable to cover the next 30-60 days of operations, less normal accounts payable. The headline TEV is calculated cash-free, debt-free, with a working capital target. The actual purchase price gets adjusted up or down at close depending on whether delivered working capital is above or below the target. Manufacturing owners who don’t negotiate the working capital target during the LOI lose $300K-$2M+ at close on midsize deals.

Inventory turns benchmarks (2024-2026 industry data): Machine shops: 4-8 inventory turns annually (relatively low inventory, mostly raw stock and work in process). Contract manufacturers: 5-10 turns. Plastic injection molders: 6-12 turns. Metal stamping: 6-10 turns. Aerospace precision: 3-6 turns (long lead-time material, certification-controlled stock). Medical device CMs: 4-7 turns (regulated material storage, lot traceability). Electronic CMs: 8-15 turns (component-heavy, fast cycle). If your inventory turns are below the low end of your sub-vertical’s range, buyers will assume slow-moving or obsolete inventory and will demand exclusion from working capital or a write-down at close.

DSO (days sales outstanding) and DPO (days payable outstanding): Manufacturing DSO typically runs 35-55 days, depending on customer mix (Tier-1 OEMs often pay net-60 or net-90, smaller industrial customers pay net-30). DPO typically runs 30-45 days for raw material and consumables. Inventory days run 45-90 days depending on sub-vertical. The cash conversion cycle (DSO + inventory days − DPO) is what the buyer’s working capital target gets calibrated to. A precision machine shop with 50-day DSO, 75-day inventory days, and 35-day DPO has a 90-day cash conversion cycle — which on $14M of revenue translates to roughly $3.5M of working capital the buyer expects to receive at close.

The peg negotiation in the LOI. The working capital peg is typically calculated as a trailing 12-month average (sometimes 24-month average to smooth seasonality), excluding cash, debt, and any deal-related items. Manufacturing businesses with seasonal patterns (HVAC component CMs, agricultural machinery CMs, pool and spa equipment CMs) need to be especially careful: a 12-month trailing average closing in a peak-inventory month systematically over-delivers working capital. A skilled M&A advisor or QoE provider will negotiate a seasonally adjusted peg or a peak-trough corridor. Without that, the seller can give back $500K-$1.5M at close on a $20M deal — and most owners only realize this in the final week.

Excess cash and debt-free / cash-free mechanics. Cash sitting in the operating account at close is typically retained by the seller (the deal is ‘cash-free’). Debt is paid off at close from proceeds (the deal is ‘debt-free’). Equipment leases that are economically debt are usually treated as debt and reduce the equity check. Operating leases for facilities are not. The classification of equipment financing (capital lease, equipment finance loan, sale-leaseback) materially affects the equity proceeds and is one of the first things a sophisticated QoE provider will scrub.

Customer concentration: the 25% / 40% / 50% thresholds and how buyers price them

Customer concentration is the single biggest qualitative risk factor in manufacturing M&A. Buyers price concentration on a sliding scale: under 15% concentration is treated as broadly diversified and earns no discount. 15-25% concentration is acknowledged but rarely repriced. 25-40% concentration triggers a 0.5-1.5 turn multiple discount and conversations about earnouts or escrow. 40-50% concentration pushes most LMM PE platforms to require an earnout structure tied to customer retention. Above 50% concentration, the deal becomes a partnership story rather than a clean sale — multiples compress 1.5-3 turns and structure becomes heavily contingent.

Why concentration matters more in manufacturing than in service businesses. Manufacturing customer relationships are typically embedded in OEM supply chains with long qualification cycles (12-36 months for aerospace, 6-18 months for medical device, 3-12 months for industrial). The lock-in is real — but the fall is also catastrophic. Losing a 35% Boeing program to a competitor through a re-quote isn’t recoverable in 6 months; it’s recoverable in 2-4 years if at all. Buyers know this. Audax Industrial, Industrial Growth Partners, Sterling Group, and disciplined family offices will model the ‘what if’ of losing the top customer and discount the multiple to compensate.

How sophisticated buyers stress-test concentration. They will request 36-60 months of customer-by-customer revenue history. They will ask whether the contract is a long-term agreement (LTA) or a series of purchase orders. They will ask about pricing reset mechanisms (annual, biennial, indexed to commodity prices). They will ask whether the customer relationship runs through one or two engineers at the OEM (key-person risk on the customer side). They will ask whether you have qualified second-source suppliers or whether you are sole-sourced (sole-source positions are stickier but riskier if the OEM dual-sources). They will ask about recent re-quotes or RFQs you’ve participated in.

Mitigations that protect the multiple. Long-term agreements with 3-5 year terms and pricing escalators. Sole-source designations on critical part numbers. Embedded engineering relationships (your application engineer is in the OEM’s product development meetings). Capacity reservation agreements where the OEM has paid for dedicated production capacity. AS9100 / ISO 13485 / NADCAP certifications that make switching costly for the OEM. Multi-program presence at a single OEM (you’re not just on one Boeing program; you’re on 12 across three OEM business units). Each of these meaningfully reduces the practical concentration risk and the discount the buyer applies.

Recurring versus project revenue: the contracted-revenue premium

Recurring contracted revenue is the single biggest multiple-expander in manufacturing. Buyers pay materially more for businesses where 60%+ of revenue is under multi-year contracted supply agreements with built-in volume commitments and pricing escalators than they do for businesses with the same EBITDA derived from project-based work or transactional purchase orders. The reasoning is straightforward: contracted revenue is forecastable, recession-resistant within OEM cycles, and supports higher leverage in the buyer’s capital structure.

What counts as ‘recurring’ in manufacturing. Multi-year supply agreements (LTAs) with stated volume commitments. Production parts on an OEM bill of materials with a sole-source or qualified-second-source designation. Aftermarket service parts where the OEM has installed base of equipment that will continue to need replacement parts for 10-20+ years (NYSE: HEICO [HEI] built a $20B+ market cap on this thesis in aerospace aftermarket). Repeat-order industrial commodity production (gaskets, fasteners, bearings, hydraulic components) where customer churn is structurally low.

What does NOT count as recurring. ‘Repeat customers’ without contracted volume commitments are not recurring — they are loyal. Repeat customers can disappear in a single quarter if a competitor under-quotes a re-bid. Project-based work for the same customer (custom tooling, one-off fabrications, prototype runs) is not recurring even if the customer comes back annually. Maintenance, repair, and overhaul (MRO) work for industrial customers is borderline — if it’s under a multi-year service contract, it counts; if it’s ad-hoc, it doesn’t.

Multiple impact of recurring contracted revenue percentage. A precision machining business with 70%+ recurring contracted revenue trades at the top of its band (7-8x EBITDA). The same business with 30% recurring trades at the bottom (5-6x EBITDA). A 1-2 turn multiple expansion is real and sustainable when you can document the contract structure. Sophisticated buyers like GenNx360, Audax Industrial, Industrial Growth Partners, and Greenbriar Equity Group will request the underlying contracts and verify volume commitments and pricing escalation mechanisms during diligence. Owners who claim 70% recurring revenue but cannot produce the LTAs lose credibility and the multiple compresses.

Gross margin trends and operational benchmarks buyers actually look at

EBITDA is not the only number buyers care about. Gross margin trend (24-36 months) is one of the first metrics a manufacturing buyer’s deal team reviews. A flat or expanding gross margin signals pricing power and operational discipline. A compressing gross margin signals competitive pressure, raw material cost pass-through failure, or operational issues — any of which compresses the multiple. The Manufacturers Alliance (MAPI) and IBISWorld manufacturing reports both publish sub-vertical gross margin benchmarks that buyers reference.

Typical gross margin ranges by sub-vertical (2024-2026): General machine shops: 28-38% gross margin. Contract manufacturers (commodity): 18-28% gross margin. Precision machining: 32-42% gross margin. Aerospace precision (AS9100): 35-48% gross margin. Medical device CMs (ISO 13485): 35-45% gross margin. Plastic injection molding: 22-32% gross margin (resin pass-through compresses headline margin). Electronic contract manufacturing: 12-22% gross margin (component cost pass-through). If your gross margin sits at the high end of your sub-vertical’s range and has expanded over 36 months, buyers will pay a premium. If it sits at the low end and has compressed, expect a discount.

Labor efficiency and shop-floor productivity metrics. Revenue per employee is a standard benchmark: $200-300K for general machine shops, $250-400K for precision machining, $300-500K for aerospace precision, $400-700K for highly automated medical device CMs. Direct labor as a percentage of revenue: 18-28% for most manufacturing sub-verticals. Indirect labor (supervisors, quality inspectors, engineers, schedulers, customer service): 8-14% of revenue. Buyers will compare your numbers against these benchmarks and ask why you’re different. Be ready with answers.

Quality metrics and customer-facing operational KPIs. On-time delivery (OTD) percentage: top-quartile manufacturers run 95-98% OTD; bottom-quartile run 80-88%. First-pass yield (FPY) on production parts: top-quartile 97-99%; bottom-quartile 88-93%. PPM (parts per million) defect rates for aerospace and medical: top-quartile manufacturers run sub-100 PPM; bottom-quartile run 500-2,000 PPM. Customer-facing scorecards (the customer’s formal quality and delivery rating of you) are often disclosed during diligence. A ‘Tier-1 supplier’ or ‘preferred supplier’ designation from a major OEM is a meaningful multiple-supporter; a probationary or watchlist status is a meaningful multiple-compressor.

EBITDA add-backs in manufacturing: what survives QoE and what doesn’t

Add-backs in manufacturing follow the same general framework as other sectors but with sub-vertical-specific nuances. A quality of earnings (QoE) provider — typically Plante Moran, BDO Manufacturing & Distribution practice, RSM, Crowe, Wipfli, Eide Bailly, or Cohn Reznick for manufacturing-focused engagements — will scrub every add-back you propose against documentation, recurrence, and reasonableness. Aggressive add-backs that don’t survive scrutiny re-price the deal.

Add-backs that consistently survive QoE in manufacturing: Owner’s above-market compensation (the gap between owner’s actual W-2 plus benefits and a market-rate plant manager / GM salary — typically $100-200K of add-back). Family members on payroll without market-rate roles. One-time legal fees from a settled lawsuit. One-time costs of an ERP implementation (Epicor, Plex, IQMS, Global Shop Solutions, Made2Manage). Severance from a documented one-time RIF. Owner’s personal vehicle, phone, and travel (with documentation). Country club, hunting lease, and similar discretionary perks. Non-recurring R&D costs for a specific failed product line. Equipment lease normalization (operating lease being recharacterized to ownership-equivalent depreciation).

Add-backs that buyers and QoE providers reject or heavily discount: ‘Inefficiencies the new owner will fix’ (synergies belong to the buyer, not the seller). Tooling and prototyping costs that recur on a 3-5 year cycle (these are normal capex, not one-time). Equipment maintenance that has been deferred (deferred capex is not an add-back — it’s a future liability). Owner’s sales commissions if the owner is the lead salesperson and a replacement salesperson would earn similar commissions. Customer entertainment and travel that is genuinely operational. Bad debt write-offs that recur historically.

Manufacturing-specific add-backs worth highlighting. Owner labor on the shop floor (the owner who runs a CNC machine 20 hours a week): this is real labor that needs to be replaced — either as a salaried operator or a fractional shop supervisor. The add-back is the gap between current owner cost and replacement cost. R&D capitalization: sophisticated manufacturers capitalize R&D for new product development; QoE providers will normalize this if your treatment is inconsistent. Equipment lease normalization: operating leases that are economically equivalent to ownership should be treated as debt with corresponding depreciation, not as an operating expense. This often shifts $100-500K of EBITDA on midsize deals. Inventory reserve adjustments: a one-time write-down of slow-moving inventory in a prior period should be adjusted out of the comparison base.

Who actually buys manufacturing businesses in 2026 (and what they pay)

The manufacturing buyer pool in 2026 divides into five archetypes, each with different check sizes, multiple ranges, and structural preferences. Knowing which archetype matches your business is the highest-leverage positioning decision you make. Mismatched outreach (running a process to LMM PE platforms when your business is sub-$2M EBITDA owner-operated) wastes 6-9 months. The 76+ buyer network we work with includes 38 firms with explicit manufacturing mandates — these are the active, disciplined, multi-deal-per-year buyers actually writing checks.

Archetype 1: Manufacturing-focused LMM private equity platforms. Examples: Audax Industrial Services, Industrial Growth Partners, GenNx360 Capital Partners, Trive Capital, Mason Wells, Wynnchurch Capital, Argosy Capital, Sterling Group, Cortec Group, GTCR’s industrials practice, Genstar Capital industrial investments. Check size: $5-50M+ of equity per deal; total enterprise values $20-300M+. Multiples: 6-9x for $5-25M EBITDA, 7-10x for $25-50M EBITDA. Hold period: 3-7 years. Value-creation thesis: operational improvement, add-on acquisitions, end-market diversification, geographic expansion. They want clean books, real second-tier management, recurring contracted revenue, and at least ISO 9001 quality systems.

Archetype 2: Mega-cap PE industrial groups (upper LMM and middle market). Examples: KKR Industrials and Global Infrastructure Partners (now part of BlackRock), Carlyle Industrials, Onex Partners industrial investments, Bain Capital industrials practice, Apollo Global Management industrials. Check size: $50-500M+ of equity per platform; TEV $200M-$2B+. Multiples: 8-12x for $25-100M EBITDA, 9-15x for $100M+ EBITDA with strong growth or strategic positioning. They typically buy platforms and use add-on programs to roll up sub-scale targets. They want $25M+ EBITDA, $100M+ revenue, defensible market positions, and growth runway.

Archetype 3: Public strategic consolidators. Examples: NYSE: APi Group (APG — specialty contractor consolidation), NYSE: Watsco (WSO — HVAC distribution), NYSE: Comfort Systems USA (FIX — mechanical contractor consolidation), NYSE: Roper Technologies (ROP — niche industrial software and equipment), NASDAQ: HEICO (HEI — aerospace aftermarket), NYSE: Atkore (ATKR — electrical raceway and conduit), TransDigm (proprietary aerospace components). Check size: $20M-$1B+ for tuck-in to platform. Multiples: often premium to LMM PE because synergies justify it — 9-14x EBITDA for the right strategic fit. Process: corporate development teams source proactively; close in 60-120 days when synergies are clear. They want either market-share consolidation in their existing footprint or capability expansion (new product lines, geographies, certifications).

Archetype 4: Family offices with industrial mandates. Examples: undisclosed by nature, but the 76+ buyer network includes 8-12 family offices with explicit manufacturing mandates and check sizes ranging from $5M to $100M of equity. Multiples: 5-8x EBITDA depending on situation; family offices sometimes pay premium for strategic fit with existing portfolio companies but more often pay disciplined LMM-equivalent multiples with longer hold horizons (7-15 years versus 3-5 for PE). Process: less competitive on price but often faster on close because they don’t need fund-level approvals.

Archetype 5: Search funders, independent sponsors, and SBA buyers (sub-$3M EBITDA). Search funders raise $400-700K of search capital backed by 10-20 individual investors and target $1-3M EBITDA manufacturing businesses. Independent sponsors operate deal-by-deal and target $500K-$5M EBITDA. SBA-financed individuals dominate the sub-$1M SDE machine shop market. Multiples: 3-5x SDE for sub-$1M SDE machine shops, 4-6x EBITDA for $1-3M EBITDA businesses. Process: 60-150 day close, 10-20% buyer equity, heavy reliance on seller note (often 15-30% of purchase price) and earnout structures.

How to estimate your manufacturing business value: a worked example

Let’s work through a real example: a $14M revenue precision machining business with $1.8M of TTM EBITDA, $900K of average maintenance capex, AS9100 certification, 32% concentration in a single Tier-1 OEM, and 65% recurring contracted revenue. Step 1: identify the metric. At $1.8M EBITDA with a real plant manager and controller in place, this business is correctly valued on EBITDA, not SDE. Step 2: identify the size band. $1.8M EBITDA puts this business at the lower end of LMM, with a buyer pool dominated by search funders, independent sponsors, and small LMM PE platforms. Step 3: identify the sub-vertical multiple range. AS9100 precision machining sits in the 6-8x EBITDA range as a starting point.

Step 4: apply the four adjusters. (1) Size premium / discount: at $1.8M EBITDA, this business is below the typical LMM PE platform threshold of $3-5M EBITDA, which compresses the multiple by ~0.5 turn. Adjusted base: 5.5-7.5x. (2) Recurring revenue premium: 65% recurring contracted revenue is solid, supports a +0.5 turn premium. Adjusted base: 6-8x. (3) Customer concentration discount: 32% concentration in a single Tier-1 OEM triggers a 0.75-1.25 turn discount. Adjusted base: 4.75-7.25x. (4) Growth premium / discount: assume modest 6-8% organic growth, no premium or discount. Final range: 4.75-7.25x EBITDA.

Step 5: apply capital intensity normalization. $1.8M reported EBITDA − $900K average maintenance capex = $900K of cash EBITDA. Sophisticated buyers will price closer to cash EBITDA than reported EBITDA, particularly at the lower end of the multiple range. Realistic TEV range: 4.75x × $1.8M = $8.55M on the low end (reported EBITDA basis) to 7.25x × $1.8M = $13.05M on the high end (with a buyer who underwrites reported EBITDA and pays for the AS9100 certification value).

Step 6: apply working capital and debt mechanics. Assume $2.8M of working capital target, $800K of equipment loan debt at close. TEV of $11M produces $8.2M of equity proceeds before transaction costs and taxes. After 1.5% transaction costs ($165K) and 20% blended federal capital gains plus state tax, net proceeds to seller would be ~$6.4M. Add 15-25% seller financing if structured (carrying a $2-2.5M seller note at 7-9% interest over 7-10 years), and the seller realizes the gap over time. The headline 6.1x multiple translates to roughly $6.4M of cash at close plus the seller note collected over 10 years.

Step 7: stress-test against actual recent comps. GF Data DealStats and BVR DealStats publish quarterly comps for sub-vertical and size band. Pitchbook’s industrials reports give you the LMM aggregate. Public 10-Ks for serial acquirers (NASDAQ: HEICO, NYSE: Atkore, TransDigm) disclose acquisition prices and EBITDA multiples on individual deals worth $100M+. Trade association data (AMT, NTMA, PMA, MAPI) gives you sub-vertical context. The right starting-point estimate triangulates across all of these.

Common manufacturing valuation mistakes (and how disciplined buyers exploit them)

Mistake 1: anchoring on a Pitchbook headline multiple. ‘Industrials traded at 8.4x in Q4’ describes the median across $25M+ EBITDA platform deals with strong recurring revenue and clean concentration profiles. It is not the multiple for your $2M EBITDA machine shop with 38% concentration. The most expensive owner mistake in manufacturing valuation is reading the right number for the wrong business.

Mistake 2: ignoring maintenance capex. Reported EBITDA without normalization for maintenance capex overstates underwriteable cash flow by 15-30% in most manufacturing sub-verticals. Sophisticated buyers know this. They will run the math during diligence regardless of what you tell them. Owners who walk in with a clean fixed-asset register, equipment-replacement plan, and 3-year capex history protect their multiple. Owners who don’t end up renegotiating in week 8.

Mistake 3: under-disclosing customer concentration until LOI. Many owners hide or downplay concentration in the initial CIM, hoping to attract a higher LOI and then negotiate during diligence. This always backfires. Sophisticated buyers (Audax Industrial, Industrial Growth Partners, Sterling Group) will request 36-60 months of customer-by-customer revenue history during LOI diligence, find the concentration, and re-trade aggressively. The LOI re-trade kills more manufacturing deals than any other single factor. Disclose upfront with the mitigation story.

Mistake 4: poor working capital documentation. Manufacturing working capital is complex (inventory categories, customer-funded inventory, consignment, work in process, finished goods, raw material). Owners who can’t produce a 24-36 month working capital trend report by category lose the working capital negotiation by default. The buyer will define the peg using whatever data is available, and the owner discovers $500K-$2M of missing value at close.

Mistake 5: shopping the deal too broadly. Manufacturing M&A is a small world. The 38 manufacturing-focused buyers in the LMM universe talk to each other — deal teams overlap, advisors get hired across funds, and a deal that’s been shopped to all 38 platforms is a stale deal by month 4. Targeted outreach to 5-12 buyers who specifically match your sub-vertical, size, and certification profile beats broad auction marketing every time. This is the structural advantage of working with a buy-side partner who knows the buyers personally.

Mistake 6: hiring the wrong QoE provider. Manufacturing has sub-vertical-specific accounting nuances (R&D capitalization, equipment lease treatment, inventory reserve methodology, labor cost allocation, overhead absorption rates) that a generalist QoE provider will miss or get wrong. The QoE providers with deep manufacturing benches — Plante Moran, BDO Manufacturing & Distribution, RSM Manufacturing & Distribution, Crowe, Wipfli, Eide Bailly, Cohn Reznick — are worth the modest premium versus a generalist firm. A bad QoE creates re-trades; a good one prevents them.

When professional valuation is worth paying for (and when it isn’t)

Three situations where a paid third-party manufacturing valuation is worth $8-25K: (1) You’re planning an estate gift or buy-sell agreement and need an IRS-defensible Section 409A or 706 valuation. (2) You’re funding an ESOP transition and need a fairness opinion compliant with DOL standards. (3) You’re in shareholder litigation or marital dissolution and need a credentialed appraiser’s report. In these cases, hire a credentialed appraiser (ASA, ABV, CVA) with manufacturing experience — firms like Mercer Capital, Empire Valuation Consultants, or the valuation arms of Plante Moran, BDO, and RSM.

Situations where a paid valuation is overkill for sale planning: If you’re 12-24 months out from a potential sale and just want a starting-point valuation range, a free buy-side conversation with someone who knows the manufacturing buyer pool is more useful than a $15K credentialed appraisal. The credentialed appraisal will produce a single point estimate based on standardized methodology; the buyer conversation will produce a range tied to actual buyer appetite, sub-vertical multiples, and structural deal mechanics. The latter is what you actually need to make planning decisions.

What to ask for in a sale-planning valuation conversation. (1) Realistic multiple range for my sub-vertical at my size band. (2) The 3-5 specific buyer archetypes who would actually look at my business. (3) Which of my financial or operational metrics need 12-24 months of cleanup before going to market. (4) The structural risks (customer concentration, capex intensity, owner dependency) that will compress my multiple unless mitigated. (5) Whether waiting 12-24 months to grow into a higher size band or cleaner concentration profile would produce more after-tax proceeds than selling now.

How CT Acquisitions runs this conversation. We work directly with 76+ active U.S. lower middle-market buyers, including 38 firms with explicit manufacturing mandates. Buyers pay us when a deal closes. You pay nothing — no retainer, no contract. A 30-minute call gives you a real read on which buyers in our network would actually look at your business, what they’d realistically pay, and what 12-24 months of preparation would change. If none of it is useful, you’ve lost 30 minutes. If it is, you’ve shortcut what most owners spend 6-12 months and $200-500K of advisor fees to find out.

Building a 24-month plan to maximize your manufacturing valuation

The owners who realize the highest manufacturing multiples are the ones who started prepping 18-24 months before going to market. At this size, you cannot fix everything in 90 days. Customer diversification takes 12-18 months. Recurring contract conversion takes 6-18 months of LTA negotiation. Quality certifications (AS9100, ISO 13485) take 9-15 months from kickoff to certification. Owner dependency reduction takes 12-24 months of intentional delegation. Skipping the prep work doesn’t produce a faster exit; it produces a worse one.

Months 24-18: financial cleanup and ERP discipline. Move to monthly closes within 15 days. Reconcile bank, AR, AP, and inventory accounts to the books monthly. Get CPA-prepared (not just bookkeeper-prepared) annual financial statements; if budget allows, reviewed financials ($15-30K/year for manufacturing). Migrate to or stabilize a real manufacturing ERP (Epicor, Plex, IQMS, Global Shop, ProShop). The cost of an ERP migration is real ($75-300K) but the buyer-perceived value is significantly higher — messy financials in spreadsheets compress multiples by 0.5-1 turn.

Months 18-12: customer diversification and contract conversion. Identify top customer concentration risks. Build a 12-month customer acquisition plan to add 5-15 new accounts in the $200K-$1M annual revenue range. For your top 3-5 customers, negotiate or extend long-term agreements (3-5 year terms with annual pricing escalators tied to a published index like PPI or CPI manufacturing). Migrate purchase-order-only customers to LTAs where possible. The combination of new account acquisition and contract conversion can shift recurring revenue percentage from 35% to 65% over 12-18 months — worth 1-2 turns of multiple.

Months 12-6: certification, quality systems, and operational documentation. If you don’t have ISO 9001, get it. If you serve aerospace customers without AS9100, the certification process takes 9-15 months and is worth 1-2 turns of multiple. Same for ISO 13485 (medical device) and NADCAP for special processes (heat treat, NDT, chemical processing). Document SOPs for the top 20-30 operational processes. Build a quality dashboard with on-time delivery, first-pass yield, customer scorecard ratings. Buyers pay measurably more for documented operations than for tribal-knowledge operations.

Months 6-0: diligence package preparation. Compile 36 months of monthly P&Ls, balance sheets, and cash flow statements. Build a customer-by-customer revenue history for 36-60 months. Document add-backs with line-item supporting receipts. Pull 24-month working capital trend with category breakdowns (raw, WIP, finished goods, customer-funded inventory, consignment). Compile fixed-asset register with model numbers, acquisition dates, accumulated depreciation, remaining useful life, and 5-year replacement plan. Gather all customer LTAs, supplier agreements, equipment leases, real estate leases, employment agreements, and IP / patent documentation. The cleaner the package, the faster diligence runs and the fewer surprises arise during QoE.

Conclusion

Valuing a manufacturing business is sub-vertical math, not headline math. TEV/EBITDA multiples cluster in three size bands (4-7x sub-$10M EBITDA, 6-9x $10-50M, 7-12x $50M+) but the band you actually land in depends on your sub-vertical (machine shop versus precision versus aerospace versus medical), capital intensity (4-7% maintenance capex is typical and meaningfully reduces underwriteable cash flow), customer concentration (25%/40%/50% thresholds drive 0.5-3 turns of discount), recurring contracted revenue percentage (60%+ supports premium pricing), and certifications (ISO 9001, AS9100, NADCAP, ISO 13485, FDA registration). The owners who realize the highest manufacturing multiples are the ones who clean up financials 18-24 months early, diversify customer concentration, convert PO customers to LTAs, achieve the right certifications, and present a clean diligence package. And if you want to talk to someone who knows the 38 manufacturing-focused buyers in the LMM universe personally instead of running an auction, we’re a buy-side partner — the buyers pay us, not you, no contract required.

Frequently Asked Questions

What is a typical EBITDA multiple for a manufacturing business in 2026?

TEV/EBITDA multiples in 2026 cluster in three size bands per GF Data, BVR DealStats, and Pitchbook industrials: sub-$10M EBITDA = 4-7x, $10-50M EBITDA = 6-9x, $50M+ EBITDA = 7-12x. Sub-vertical and customer concentration shift you 1-3 turns inside those bands. Aerospace (AS9100/NADCAP) and medical device (ISO 13485/FDA) trade at the top of the range; commodity contract manufacturing trades at the bottom.

When should I use SDE versus EBITDA for a manufacturing valuation?

Below ~$1.5M of normalized earnings, owner-operated job shops and machine shops are valued on SDE (Seller’s Discretionary Earnings). SDE includes the full owner compensation package — salary, bonus, benefits, perks. Buyers at this size are SBA-financed individuals or search funders who will step into the owner role. Above $1.5M-$2M of EBITDA with a real plant manager and controller in place, you should report EBITDA. The wrong choice changes apparent multiples by 25-30%.

How does capital intensity affect manufacturing valuation?

Maintenance capex of 4-7% of revenue is typical for most manufacturing sub-verticals. Sophisticated buyers underwrite EBITDA − maintenance capex (sometimes called ‘cash EBITDA’), not headline EBITDA. The gap is usually 15-30% of reported EBITDA. A $14M revenue, $2M EBITDA precision shop with $900K of maintenance capex underwrites at $1.1M of cash EBITDA — not $2M. Bring a clean fixed-asset register and 3-year capex history to protect your multiple.

What customer concentration is acceptable in manufacturing M&A?

Under 15% concentration earns no discount. 15-25% is acknowledged but rarely repriced. 25-40% triggers a 0.5-1.5 turn discount and conversations about earnouts. 40-50% pushes most LMM PE platforms to require an earnout structure tied to customer retention. Above 50%, the deal compresses 1.5-3 turns and structure becomes heavily contingent. Long-term agreements (3-5 year LTAs), sole-source designations, and certification-driven switching costs (AS9100, ISO 13485) materially reduce the practical concentration discount.

How do AS9100 and ISO 13485 certifications affect valuation?

AS9100 (aerospace quality) typically supports 7-10x EBITDA versus 4-7x for general machine shops — a 1-3 turn premium. ISO 13485 (medical device) and FDA registration support 8-12x EBITDA. NADCAP accreditation for special processes (NDT, heat treat, chemical processing) adds further premium. The reasoning is certification scarcity, OEM qualification cycles of 18-36 months that lock incumbents in, and 60-80% recurring contracted revenue from Tier-1 OEMs. ITAR-restricted defense work adds another 0.5-1 turn for U.S.-controlled buyers.

What buyer types acquire manufacturing businesses?

Five archetypes: (1) LMM PE platforms (Audax Industrial, Industrial Growth Partners, GenNx360, Trive, Mason Wells, Wynnchurch, Sterling, Argosy, Cortec, GTCR Industrials), (2) mega-cap PE industrials (KKR, Carlyle, Onex, Apollo, Bain), (3) public strategic consolidators (NYSE: APi Group [APG], Watsco [WSO], Comfort Systems [FIX], Roper [ROP], NASDAQ: HEICO [HEI], NYSE: Atkore [ATKR]), (4) family offices with industrial mandates, and (5) search funders, independent sponsors, and SBA buyers (sub-$3M EBITDA).

What working capital adjustment should I expect at close?

Manufacturing buyers expect to receive normal operating working capital at close: typically 30-60 days of receivables, plus inventory, less normal payables. The cash conversion cycle (DSO + inventory days − DPO) drives the peg. A precision machine shop with 50-day DSO, 75-day inventory days, and 35-day DPO has a 90-day cycle, translating to roughly 25% of revenue as a working capital target. On $14M revenue, that’s $3.5M. Negotiate the peg in the LOI with a seasonally adjusted methodology if your business has cyclical inventory patterns.

How do I handle EBITDA add-backs for owner labor on the shop floor?

If you’re running CNC machines, programming jobs, or estimating quotes 15-30 hours a week, that labor needs to be replaced by the buyer. The legitimate add-back is the gap between your current cost (often zero, since you don’t pay yourself separately for shop labor) and the replacement cost (a $75-110K skilled operator or estimator). Document the hours, document the role, and present the add-back with a clear staffing plan. QoE providers like Plante Moran, BDO, and RSM Manufacturing & Distribution will accept properly documented owner-labor add-backs.

How long does a manufacturing M&A process take?

Typical LMM manufacturing process: 9-12 months from prep-complete to close. Months 1-2: positioning and CIM. Months 2-4: targeted buyer outreach and management meetings. Months 4-6: LOI negotiation and exclusivity. Months 6-9: QoE, legal diligence, financing. Months 9-12: close and transition. Add 18-24 months on the front for proper preparation: financial cleanup, customer diversification, certification, owner dependency reduction. The owners who do the prep work see 1-3 turns of additional multiple at exit.

Should I get a paid third-party valuation before going to market?

Only if you have a specific need: estate planning (Section 409A/706), ESOP transition, shareholder litigation, marital dissolution. For sale planning, a free buy-side conversation with someone who knows the manufacturing buyer pool is more useful than a $10-20K credentialed appraisal. The appraisal produces a standardized point estimate; the buyer conversation produces a range tied to actual buyer appetite, sub-vertical multiples, and structural mechanics. If you do need credentialed work, hire firms with manufacturing experience: Mercer Capital, Empire Valuation, or the valuation arms of Plante Moran, BDO, and RSM.

What documentation do buyers expect during diligence?

36 months of monthly P&Ls, balance sheets, cash flow statements. 36-60 months of customer-by-customer revenue history. Documented add-backs with supporting receipts. 24-month working capital trend with category breakdowns (raw, WIP, finished goods, consignment). Fixed-asset register with model numbers, acquisition dates, accumulated depreciation, remaining useful life, and 5-year replacement plan. All customer LTAs, supplier agreements, equipment leases, real estate leases, employment agreements. Quality certifications and customer scorecards. Equipment maintenance records. Tax returns reconciled to financials within 5%.

When should I wait 12-24 months before selling my manufacturing business?

Wait if: you’re within $500K of a meaningful EBITDA threshold ($3M, $5M, $10M); customer concentration is above 30%; recurring contracted revenue is below 40%; you’re missing a relevant certification (ISO 9001, AS9100, ISO 13485, NADCAP); your books need 12-18 months of cleanup; or you’re still the operating brain (lead salesperson, lead estimator, lead programmer). Each gap closed pays back 0.5-2 turns of multiple. Sell now if: health forcing exit, partnership conflict, structural sub-vertical decline, or personal liquidity crisis.

How is CT Acquisitions different from a sell-side broker or M&A advisor?

We’re a buy-side partner, not a sell-side broker. Sell-side brokers represent you and charge you 8-12% of the deal (often $300K-$1M+) plus monthly retainers, run a 9-12 month auction process, and require 12-month exclusivity. We work directly with 76+ buyers — including 38 firms with explicit manufacturing mandates: Audax Industrial, Industrial Growth Partners, GenNx360, Trive, Mason Wells, Wynnchurch, Sterling Group, Argosy, Cortec, GTCR Industrials, family offices, and strategic consolidators — who pay us when a deal closes. You pay nothing. No retainer, no exclusivity, no contract until a buyer is at the closing table. We move faster (60-180 days from intro to close in many cases) because we already know which of the 38 manufacturing-focused buyers in the network would actually look at your business rather than running an auction to find one.

Sources & References

All claims and figures in this analysis are sourced from the publicly available references below.

1. https://www.sba.gov/funding-programs/loans/7a-loans
2. https://www.irs.gov/forms-pubs/about-form-8594
3. https://www.nam.org/
4. https://www.amtonline.org/
5. https://www.ntma.org/
6. https://www.bls.gov/iag/tgs/iag31-33.htm
7. https://www.bea.gov/data/gdp/gdp-industry
8. https://investors.heico.com/financials/sec-filings